Annual ROE
-256.90%
-118.32%-85.38%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual return on equity is -256.90%, with the most recent change of -118.32% (-85.38%) on December 31, 2023.
- During the last 3 years, AMPE annual ROE has fallen by -166.14% (-183.05%).
- AMPE annual ROE is now -139.58% below its all-time high of 649.08%, reached on December 31, 2018.
Performance
AMPE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-149.00%
-37.64%-33.80%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly return on equity is -149.00%, with the most recent change of -37.64% (-33.80%) on December 31, 2023.
- Over the past year, AMPE quarterly ROE has dropped by -52.88% (-55.01%).
- AMPE quarterly ROE is now -104.35% below its all-time high of 3428.98%, reached on March 31, 2010.
Performance
AMPE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AMPE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.4% | -55.0% |
| 3 y3 years | -183.1% | +14.3% |
| 5 y5 years | -139.6% | +94.3% |
AMPE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -310.5% | at low | -84.4% | at low |
| 5 y | 5-year | -310.5% | at low | -84.4% | +56.4% |
| alltime | all time | -139.6% | +11.1% | -104.3% | +94.3% |
Ampio Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -256.90%(+85.4%) | -149.00%(+33.8%) |
| Sep 2023 | - | -111.36%(-20.2%) |
| Jun 2023 | - | -139.53%(+27.4%) |
| Mar 2023 | - | -109.52%(+13.9%) |
| Dec 2022 | -138.58%(+121.4%) | -96.12%(-1.4%) |
| Sep 2022 | - | -97.46%(+20.6%) |
| Jun 2022 | - | -80.81%(-7.5%) |
| Mar 2022 | - | -87.38%(+4.5%) |
| Dec 2021 | -62.58%(-31.0%) | -83.60%(-2.8%) |
| Sep 2021 | - | -86.02%(-7.6%) |
| Jun 2021 | - | -93.05%(-16.9%) |
| Mar 2021 | - | -112.02%(-35.6%) |
| Dec 2020 | -90.76%(-57.1%) | -173.84%(-9.9%) |
| Sep 2020 | - | -192.88%(-43.5%) |
| Jun 2020 | - | -341.48%(+55.6%) |
| Mar 2020 | - | -219.51%(-14.6%) |
| Dec 2019 | -211.55%(-132.6%) | -256.89%(+16.0%) |
| Sep 2019 | - | -221.52%(-618.4%) |
| Jun 2019 | - | 42.73%(-94.4%) |
| Mar 2019 | - | 758.23%(-128.7%) |
| Dec 2018 | 649.08%(+327.5%) | -2638.36%(-2856.0%) |
| Sep 2018 | - | 95.73%(-45.7%) |
| Jun 2018 | - | 176.33%(-37.7%) |
| Mar 2018 | - | 283.03%(-65.1%) |
| Dec 2017 | 151.83%(-152.6%) | 810.15%(-353.8%) |
| Sep 2017 | - | -319.16%(+69.3%) |
| Jun 2017 | - | -188.52%(+13.9%) |
| Mar 2017 | - | -165.49%(+2.5%) |
| Dec 2016 | -288.86%(+233.9%) | -161.47%(+21.7%) |
| Sep 2016 | - | -132.66%(+29.3%) |
| Jun 2016 | - | -102.59%(+24.0%) |
| Mar 2016 | - | -82.76%(+25.9%) |
| Dec 2015 | -86.52% | -65.72%(+15.4%) |
| Sep 2015 | - | -56.96%(+5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | -53.90%(+7.3%) |
| Mar 2015 | - | -50.25%(-10.7%) |
| Dec 2014 | -57.66%(-31.5%) | -56.28%(-1.3%) |
| Sep 2014 | - | -57.05%(-9.2%) |
| Jun 2014 | - | -62.83%(-16.0%) |
| Mar 2014 | - | -74.83%(-14.3%) |
| Dec 2013 | -84.17%(+51.0%) | -87.29%(+12.4%) |
| Sep 2013 | - | -77.63%(-2.1%) |
| Jun 2013 | - | -79.26%(+26.0%) |
| Mar 2013 | - | -62.88%(+5.4%) |
| Dec 2012 | -55.75%(-79.1%) | -59.64%(-14.8%) |
| Sep 2012 | - | -70.01%(-14.4%) |
| Jun 2012 | - | -81.77%(-0.7%) |
| Mar 2012 | - | -82.37%(-37.5%) |
| Dec 2011 | -267.02%(-232.9%) | -131.70%(-34.8%) |
| Sep 2011 | - | -201.87%(-42.5%) |
| Jun 2011 | - | -351.30%(-74.5%) |
| Mar 2011 | - | -1377.60%(-363.9%) |
| Dec 2010 | 200.91%(-64.4%) | 521.98%(-44.0%) |
| Sep 2010 | - | 931.51%(-40.4%) |
| Jun 2010 | - | 1561.76%(-54.5%) |
| Mar 2010 | - | 3428.98%(+152.8%) |
| Dec 2009 | 564.10%(+676.2%) | 1356.18%(-18.9%) |
| Sep 2009 | - | 1671.60%(+95.7%) |
| Jun 2009 | - | 854.38%(+2242.7%) |
| Mar 2009 | - | 36.47%(-59.1%) |
| Dec 2008 | 72.67%(-72.7%) | 89.08%(-30.6%) |
| Sep 2008 | - | 128.40%(-33.0%) |
| Jun 2008 | - | 191.77%(-42.1%) |
| Mar 2008 | - | 330.96%(-21.4%) |
| Dec 2007 | 266.67%(-5433.4%) | 421.05%(-250.5%) |
| Sep 2007 | - | -279.76%(+245.4%) |
| Jun 2007 | - | -81.00%(+1700.0%) |
| Mar 2007 | - | -4.50%(+50.0%) |
| Dec 2006 | -5.00% | -3.00% |
FAQ
- What is Ampio Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual ROE year-on-year change?
- What is Ampio Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly ROE year-on-year change?
What is Ampio Pharmaceuticals annual return on equity?
The current annual ROE of AMPE is -256.90%
What is the all time high annual ROE for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual return on equity is 649.08%
What is Ampio Pharmaceuticals annual ROE year-on-year change?
Over the past year, AMPE annual return on equity has changed by -118.32% (-85.38%)
What is Ampio Pharmaceuticals quarterly return on equity?
The current quarterly ROE of AMPE is -149.00%
What is the all time high quarterly ROE for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly return on equity is 3428.98%
What is Ampio Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, AMPE quarterly return on equity has changed by -52.88% (-55.01%)